Craig Bijou
Stock Analyst at B of A Securities
(3.86)
# 636
Out of 5,182 analysts
68
Total ratings
61.54%
Success rate
68.6%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Downgrades: Underperform | $38 → $20 | $24.80 | -19.35% | 6 | Feb 26, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $82 → $92 | $61.74 | +49.02% | 3 | Jan 5, 2026 | |
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $89.22 | +2.00% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $6.78 | +32.74% | 2 | Jul 9, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $123.23 | +13.61% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $16.00 | +6.25% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $14.00 | +28.57% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $86.29 | +68.04% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $61.63 | +67.13% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $52.67 | +61.38% | 1 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $61.12 | +55.43% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $12.99 | +177.14% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $9.36 | +380.77% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $6.66 | +350.45% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $8.5 → $6.5 | $16.41 | -60.39% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $12.21 | +243.98% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $451.73 | -49.08% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $292.33 | -21.32% | 4 | Jul 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | - | - | 3 | Dec 4, 2017 |
PROCEPT BioRobotics
Feb 26, 2026
Downgrades: Underperform
Price Target: $38 → $20
Current: $24.80
Upside: -19.35%
GE HealthCare Technologies
Jan 5, 2026
Maintains: Neutral
Price Target: $82 → $92
Current: $61.74
Upside: +49.02%
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $89.22
Upside: +2.00%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $6.78
Upside: +32.74%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $123.23
Upside: +13.61%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $16.00
Upside: +6.25%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $14.00
Upside: +28.57%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $86.29
Upside: +68.04%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $61.63
Upside: +67.13%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $52.67
Upside: +61.38%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $61.12
Upside: +55.43%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $12.99
Upside: +177.14%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $9.36
Upside: +380.77%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $6.66
Upside: +350.45%
Mar 24, 2020
Reiterates: Overweight
Price Target: $8.5 → $6.5
Current: $16.41
Upside: -60.39%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $12.21
Upside: +243.98%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $451.73
Upside: -49.08%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $292.33
Upside: -21.32%
Dec 4, 2017
Downgrades: Market Perform
Price Target: n/a
Current: -
Upside: -